Zobrazeno 1 - 10
of 15 305
pro vyhledávání: '"Primary Myelofibrosis"'
Autor:
Song J; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.; Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, 100053, China.; National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China., Huang C; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.; Department of Neurology, The People's Hospital of He Chi, Hechi, China., Jia L; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.; Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, 100053, China.; National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China., Wang M; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.; Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, 100053, China.; National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China., Wu C; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.; National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China., Ji X; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.; Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, 100053, China.; National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China., Song H; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. songhaiqing@xwh.ccmu.edu.cn.; Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, 100053, China. songhaiqing@xwh.ccmu.edu.cn.; National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. songhaiqing@xwh.ccmu.edu.cn., Meng R; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. victor65@126.com.; Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, 100053, China. victor65@126.com.; National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. victor65@126.com., Zhou D; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. popdoctor@foxmail.com.; Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, 100053, China. popdoctor@foxmail.com.; National Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. popdoctor@foxmail.com.
Publikováno v:
BMC neurology [BMC Neurol] 2024 Oct 12; Vol. 24 (1), pp. 386. Date of Electronic Publication: 2024 Oct 12.
Autor:
Ibrahim M; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Murphree C; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Patel K; Delta Pathology Group, Shreveport, Louisiana, USA., Mastrodomenico M; Delta Pathology Group, Shreveport, Louisiana, USA., Saba NS; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Safah H; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Schmid J; Pathology Department, Tulane University, New Orleans, Louisiana, USA., Socola F; Hematology and Bone Marrow Transplant, University of California Davis, Sacramento, California, USA.
Publikováno v:
Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Sep; Vol. 7 (9), pp. e2054.
Autor:
Urrutia S; Division of Oncology, Washington University in St Louis, St Louis, 200233, USA., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Ravandi-Kashani F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Dinardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA. ksasaki1@mdanderson.org.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Nov 15; Vol. 17 (1), pp. 112. Date of Electronic Publication: 2024 Nov 15.
Autor:
Ghalehsari N; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York; NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York., Castillo Tokumori F; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Chen Z; Division of Biostatistics, Department of Population Science, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Liu M; NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York., Mayer SA; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Zeinah GA; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Shore TB; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Ritchie EK; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Silver RT; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Scandura JM; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Roboz GJ; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., van Besien K; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York; UH Seidman Cancer Center, Cleveland, Ohio., Gomez-Arteaga A; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York. Electronic address: alg9117@med.cornell.edu.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Nov; Vol. 30 (11), pp. 1100.e1-1100.e11. Date of Electronic Publication: 2024 Sep 05.
Autor:
Ngo D; Department of Pharmacy, City of Hope, Duarte, CA, USA., Tinajero J; Department of Pharmacy, City of Hope, Duarte, CA, USA., Ladha A; Department of Medicine, Blood and Marrow Transplant Hematology, Keck Medicine of University of Southern California, Los Angeles, CA, USA., Malki MMA; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Otoukesh S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Amanam I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA., Ali H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA. Electronic address: harisali@coh.org.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Nov; Vol. 30 (11), pp. 1091.e1-1091.e8. Date of Electronic Publication: 2024 Aug 24.
Autor:
Okada Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke., Kawamura S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Takano K; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Yoshimura K; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Tamaki M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Matsuoka A; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Ishikawa T; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Meno T; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Nakamura Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Kawamura M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Takeshita J; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Yoshino N; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Misaki Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Kusuda M; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Tanihara A; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Kimura SI; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama., Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama. ycanda-tky@umin.ac.jp.
Publikováno v:
Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3593-3601. Date of Electronic Publication: 2024 Nov 01.
Autor:
Slowley A; GSK, Value, Evidence and Outcomes Europe, London, UK., Weinmann S; GSK, Munich, Germany., d'Estrube T; GSK, Value, Evidence and Outcomes Europe, London, UK., Phiri K; GSK, Collegeville, Pennsylvania, USA., Karl FM; GSK, Munich, Germany., Gleißner E; GSK, Munich, Germany., Mueller S; IPAM, Wismar, Germany., Junker S; Ingress-Health HWM GmbH, a Cytel Company, Berlin, Germany., Göthert JR; Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), University Hospital Essen, Germany.
Publikováno v:
European journal of haematology [Eur J Haematol] 2024 Nov; Vol. 113 (5), pp. 704-715. Date of Electronic Publication: 2024 Aug 05.
Autor:
Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: n.gagelmann@uke.de., Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Gupta V; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., McLornan DP; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK., Vachhani P; Department of Medicine, O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, AL., Al-Ali HK; Krukenberg Cancer Center, University Hospital Halle, Halle, Germany., Ali H; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Treskes P; IQVIA CSMS Germany GmbH, Mannheim, Germany., Buckley S; Sobi Inc., Waltham, MA., Roman-Torres K; Sobi Inc., Waltham, MA., Scott B; Transplantation Program, Fred Hutchinson Cancer Research Center, Seattle, WA.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Nov; Vol. 24 (11), pp. 796-803. Date of Electronic Publication: 2024 Jul 02.
Autor:
Homma S; Department of Medical Intern Center, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.; Department of Hematology, Nippon Medical School, Tokyo, Japan., Ogasawara T; Department of Medicine, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan., Suga M; Department of Diagnostic Pathology, Tokyo Women's Medical University Adachi Medical Center, 4-33-1, Kohoku, Adachi-ku, 123-8558, Tokyo, Japan., Nakamura Y; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-Ku, Yokohama, 241-8515, Japan., Takenaka K; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-Ku, Yokohama, 241-8515, Japan.; TR Company, Shin Nippon Biomedical Laboratories, Ltd., Kagoshima, Japan., Marshall S; Department of Medicine, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan., Kawauchi K; Department of Medicine, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan., Mori N; Department of Medicine, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.; Department of Hematology, International University of Health and Welfare Narita Hospital, Narita, Japan., Kuroda H; Department of Diagnostic Pathology, Tokyo Women's Medical University Adachi Medical Center, 4-33-1, Kohoku, Adachi-ku, 123-8558, Tokyo, Japan., Nakamura N; Department of Pathology, Tokai University School of Medicine, Isehara, Japan., Miyagi Y; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-Ku, Yokohama, 241-8515, Japan., Masunaga A; Department of Diagnostic Pathology, Tokyo Women's Medical University Adachi Medical Center, 4-33-1, Kohoku, Adachi-ku, 123-8558, Tokyo, Japan. nonkoamesho0324@yahoo.co.jp.; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, 2-3-2 Nakao, Asahi-Ku, Yokohama, 241-8515, Japan. nonkoamesho0324@yahoo.co.jp.
Publikováno v:
Journal of medical case reports [J Med Case Rep] 2024 Oct 30; Vol. 18 (1), pp. 510. Date of Electronic Publication: 2024 Oct 30.
Autor:
Barbui T; FROM, Fondazione per la Ricerca Ospedale di Bergamo ETS, Bergamo, Italy. tbarbui@fondazionefrom.it., Ghirardi A; FROM, Fondazione per la Ricerca Ospedale di Bergamo ETS, Bergamo, Italy., Carobbio A; Dipartimento di Scienze Mediche e Chirurgiche, Materno-Infantili e dell'Adulto, Università di Modena-Reggio Emilia, Modena, Italy., De Stefano V; Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Rome, Italy.; Fondazione Policlinico Universitario A. Gemelli Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Rambaldi A; Divisione di Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy.; Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano, Milan, Italy., Tefferi A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Vannucchi AM; CRIMM, Azienda Ospedaliera Universitaria Careggi, Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze, Florence, Italy.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Oct 25; Vol. 14 (1), pp. 188. Date of Electronic Publication: 2024 Oct 25.